EMEA-001357-PIP01-12-M02
Table of contents
Key facts
Active substance |
|
Therapeutic area |
Uro-nephrology
|
Decision number |
P/0355/2018
|
PIP number |
EMEA-001357-PIP01-12-M02
|
Pharmaceutical form(s) |
Prolonged-release granules
|
Condition(s) / indication(s) |
Treatment of renal tubular acidosis
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Advicenne Pharma
E-mail: contact@advicenne.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001357-PIP01-12-M02
|
Compliance opinion date |
15/11/2019
|
Compliance outcome |
positive
|